Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Vaccine
|
August 1, 1996
Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization
S C Hsu, E B Schadeck, A Delmas, et al.
Immunology
|
January 1, 1991
High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease
M W Steward, C M Stanley, R Dimarchi, et al.
Molecular Immunology
|
May 1, 1992
Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates
A Johnston, G R Auda, M A Kerr, et al.
Molecular Immunology
|
December 1, 1988
The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation
W W Stewart, A Johnson, M W Steward, et al.
Molecular Immunology
|
May 1, 1990
The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation
W W Stewart, A Johnson, M W Steward, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 21, 1999
Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles
C D Partidos, P Vohra, D H Jones, et al.
The Journal of Infectious Diseases
|
September 1, 1995
The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients
D Chargelegue, C M Stanley, C M O'Toole, et al.
Clinical and Experimental Immunology
|
February 1, 1995
The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression
D Chargelegue, C M Stanley, C M O'Toole, et al.
Clinical and Experimental Immunology
|
January 1, 1988
Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions
M W Steward, B M Sisley, C Stanley, et al.
Reviews of Infectious Diseases
|
November 1, 1985
Variations in host responses and the pathogenesis of human onchocerciasis
C D Mackenzie, J F Williams, B M Sisley, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Vaccine
|
August 1, 1996
Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization
S C Hsu, E B Schadeck, A Delmas, et al.
Immunology
|
January 1, 1991
High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease
M W Steward, C M Stanley, R Dimarchi, et al.
Molecular Immunology
|
May 1, 1992
Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates
A Johnston, G R Auda, M A Kerr, et al.
Molecular Immunology
|
December 1, 1988
The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation
W W Stewart, A Johnson, M W Steward, et al.
Molecular Immunology
|
May 1, 1990
The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation
W W Stewart, A Johnson, M W Steward, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 21, 1999
Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles
C D Partidos, P Vohra, D H Jones, et al.
The Journal of Infectious Diseases
|
September 1, 1995
The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients
D Chargelegue, C M Stanley, C M O'Toole, et al.
Clinical and Experimental Immunology
|
February 1, 1995
The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression
D Chargelegue, C M Stanley, C M O'Toole, et al.
Clinical and Experimental Immunology
|
January 1, 1988
Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions
M W Steward, B M Sisley, C Stanley, et al.
Reviews of Infectious Diseases
|
November 1, 1985
Variations in host responses and the pathogenesis of human onchocerciasis
C D Mackenzie, J F Williams, B M Sisley, et al.
Page
of 14